NDC Code(s) : 72789-286-60
Packager : PD-Rx Pharmaceuticals, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Divalproex sodiumDivalproex sodium TABLET, EXTENDED RELEASE | ||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
LABELER - PD-Rx Pharmaceuticals, Inc.(156893695) |
REGISTRANT - PD-Rx Pharmaceuticals, Inc.(156893695) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
PD-Rx Pharmaceuticals, Inc. | 156893695 | repack(72789-286) |
PRINCIPAL DISPLAY PANEL
Divalproex Sodium Extended-release Tablets, USP
250 mg Valproic Acid Activity
Rx only
Dispense with Medication Guide provided separately to each patient.